Performance Playbooks › Strategy › Research & Development
Building R&D pipelines that reliably convert spending into revenue
Discover the operational structure that separates predictable innovation from sporadic breakthroughs—and how to measure the speed and reliability of your development funnel. Learn which metrics matter most and the practices that keep validated ideas moving toward commercial launch.
The step from strong to world-class R&D performance is not primarily a difference in how you choose projects—it's a difference in how fast validated ideas move to market, and how reliably you convert R&D spending into revenue. World-class organizations achieve this through deliberate funnel optimization, translational bridging between research and commercialization, and protected resource allocation that removes structural friction from development workflows. Strong performers have good individual projects; world-class performers have fast, predictable pipelines that consistently deliver.
How performance compares
| Metric | Minimum | Strong | World-class |
|---|---|---|---|
| R&D Investment as Percentage of RevenueAnnual spending on research, development, and innovation activities expressed as a share of total company revenue. | 2-4% | 4-7% | 7-12% |
| Time from Concept to Commercial LaunchThe elapsed calendar time required to move a new product or service from initial business case approval through to market introduction. | 180-270 | 120-180 | 60-120 |
| R&D Portfolio Success RateThe percentage of projects initiated through the full R&D pipeline that achieve commercial launch and meet or exceed business case targets. | 15-25% | 25-40% | 40-55% |
| R&D Efficiency RatioRevenue generated from products or services launched in the past three years, divided by cumulative R&D spending over the same period. | 0.8-1.2 | 1.2-2.0 | 2.0-3.5 |
| Development Team Capacity UtilizationThe percentage of available engineering and development labor hours allocated to active projects versus total capacity, excluding training and administrative overhead. | 65-75% | 75-85% | 85-92% |
| Patent and Intellectual Property Generation RateThe annual count of patents filed, granted, or other IP protections (trademarks, trade secrets) generated per dollar of R&D investment. | 0.5-1.0 | 1.0-2.0 | 2.0-4.0 |
The gap between strong and world-class widens most noticeably in cycle time and efficiency ratio. Moving from 120–180 days to 60–120 days concept-to-launch reflects not incremental process improvement but fundamental elimination of hand-off delays, rework loops, and advance-then-retreat stage-gate patterns. The efficiency ratio gap—from 1.2–2.0 to 2.0–3.5—tells the same story: each dollar of R&D spending in world-class organizations generates significantly more near-term revenue because projects advance faster and succeed more often. Portfolio success rate spread (25–40% to 40–55%) indicates that stronger up-front screening and disciplined stage advancement criteria compound over time, reducing capital waste on projects that consume resources without reaching market. The most costly gap is in development team utilization: strong organizations run at 75–85% capacity and retain agility to pursue emerging opportunities; world-class operates at 85–92%, signaling ruthless portfolio discipline and prioritization without sacrificing flexibility. Low utilization below 75% is often invisible to leadership until pipeline predictability breaks down during a market shift.
Benchmarks for your industry
The ranges above are cross-industry. This process also has industry- and sector-specific benchmarks — see yours alongside these in Ask Kepler.
See your industry’s benchmarks →What it takes to reach world-class
Advancing from strong to world-class requires addressing a structural reality: most development organizations are optimized for execution quality on known projects, not for speed or breakthrough throughput. Stage-gate processes, designed to reduce risk, often introduce redundancy—projects advance, are reviewed again, retreat for rework, then advance again—turning the pipeline into a series of decision nodes rather than a flow. Cross-functional handoffs accumulate calendar time even when individual teams work efficiently. Translational gaps isolate research from commercial timelines, leaving promising discoveries stranded in development limbo. Many organizations recognize these patterns but struggle to address them because the fixes require simultaneous change: clarifying advancement criteria so gates don't repeat, aligning translational teams between research and commercialization, and carving protected time for development work so urgent operational demands don't starve the pipeline. Each of these moves feels risky in isolation—loosening a gate, moving translational resources, protecting calendar time from quarterly pressure—which is why most organizations stay in the strong tier, optimizing existing flows rather than redesigning them.
The route to world-class begins with transparency into where your pipeline actually stalls. Funnel velocity analysis—tracking how long projects spend in each stage and which projects advance versus languish—reveals whether delays are systemic or project-specific. If projects routinely take 90+ days moving between stages despite working teams, the friction is structural, not capability-driven. Once identified, the fix is precise: eliminate redundant review gates, establish explicit advancement criteria so gatekeepers apply consistent standards, and create a translational bridge explicitly responsible for moving research findings into development scope. Simultaneously, ring-fence development capacity—dedicating a meaningful portion to emerging high-priority work—so resource reallocation doesn't starve core projects. These changes compound: faster cycle times free resources, which enable more parallel projects, which increases success rate and ROI. The gap closes fastest when leadership treats pipeline velocity as a strategic metric tracked alongside project selection and finances.
Metric by metric
R&D Investment as a Share of Revenue
The critical lever here is alignment between investment intensity and your competitive strategy. If you compete on product differentiation or market adjacency, underfunding R&D relative to peers guarantees slower innovation velocity and eventual margin compression. You know investment is calibrated correctly when your pipeline health metrics—cycle time, success rate, portfolio throughput—are stable or improving year-over-year despite market pressure. Track not just total R&D spending but its composition: how much funds breakthrough exploration versus incremental improvement versus translational work. Misaligned composition often indicates that urgent operational needs are consuming resources meant for discovery.
Get the full R&D Investment as Percentage of Revenue playbook →Time from Concept to Commercial Launch
Cycle time is the single most revealing metric of your development system's efficiency. The primary lever is stage-gate process clarity: if advancement criteria are explicit and applied consistently, projects don't waste calendar time in redundant reviews or retreating after advancing. Measure time spent in each stage—research, development, validation, commercial preparation—to identify where delays accumulate. Most organizations find that 30–40% of total cycle time is handoff and waiting, not active work. You know you're improving when projects move between stages with minimal calendar delay while maintaining quality gates, and when slow projects can be diagnosed and redirected within days rather than weeks.
Get the full Time from Concept to Commercial Launch playbook →R&D Portfolio Success Rate
Success rate improvement depends on two levers working together: tighter up-front screening to avoid launching weak projects into development, and disciplined mid-project decision-making to stop projects early if they diverge from business case assumptions. The most common failure is weak stage gates that advance marginal projects because gatekeepers lack clear criteria or pressure builds to maintain headcount. You know screening is effective when the ratio of projects initiated to projects completing development improves, and when projects that do advance reach commercial launch within their business case timeline and cost. Track both commercial success (revenue, margin) and project success (hit business case targets) separately—projects can launch and fail commercially if market assumptions proved wrong.
Get the full R&D Portfolio Success Rate playbook →R&D Efficiency Ratio
This metric directly measures whether R&D spending converts to revenue, making it essential for securing sustained funding. The primary lever is portfolio composition: organizations with higher efficiency ratios typically allocate a meaningful portion of development capacity to near-market innovations—adjacent products, customer-specific solutions, performance improvements—that generate revenue quickly, rather than concentrating entirely on longer-cycle breakthroughs. You know this ratio is healthy and improving when new product revenue grows faster than R&D spending, and when you can attribute specific revenue streams to specific R&D investments with clear time-to-payback. This metric pairs with cycle time: faster cycles mean R&D spending converts to revenue faster, improving the ratio even before efficiency gains occur.
Get the full R&D Efficiency Ratio playbook →Development Team Capacity Utilization
The leverage point is conscious portfolio constraint: utilization below 75% usually signals either resource oversupply or weak prioritization, while above 92% means your team has no flexibility to respond to emerging priorities or unexpected challenges. Strong organizations operate at 75–85% and make deliberate decisions about when to add capacity or when to constrain the pipeline. You know utilization is well-managed when project cycle times remain stable despite portfolio pressure, when teams report sustainable workload, and when emerging high-priority work can be accommodated through portfolio rebalancing rather than always being declined or delayed.
Get the full Development Team Capacity Utilization playbook →Patent and Intellectual Property Generation Rate
IP generation depends on two things: whether your R&D produces patentable inventions, and whether you have a formalized process to capture, evaluate, and file. Organizations with low IP rates often lack the second element—inventions emerge but aren't systematically identified or routed to legal. The primary lever is embedding IP screening into early development stages, so inventors get feedback on patentability and competitive white space before finalizing designs. You know this is working when the ratio of inventions disclosed to patents filed is stable and healthy, indicating that your team surfaces patentable ideas and your IP counsel efficiently processes them, rather than portfolio-wide filing rate being driven by a few prolific inventors.
Get the full Patent and Intellectual Property Generation Rate playbook →Proven approaches
Translational Innovation: Bridging Research to Commercial Reality
The translation gap—where research breakthroughs sit unshipped because they're scientifically sound but commercially incomplete—is invisible to many organizations until projects stall. This practice creates dedicated roles and decision gates focused on converting research findings into viable development scope: timeline realism, cost modeling, regulatory pathway clarity, and market timing alignment. A translational team sits between basic research and product development, asking which findings are commercially ready now, which need further maturation, and which should be archived. This eliminates the handoff failure where researchers assume engineering will implement breakthroughs, and engineering assumes research has solved the hard problems. With translational bridging, cycle times compress because development doesn't start until scope is commercially real, and waste decreases because research teams understand which directions have commercial viability windows.
Leading Practice Report
Full detail: Translational Innovation & Applied Research Bridging
The full report covers:
- Expected benefits
- Core principles
- Key success factors
- Key metrics
- Risks and mitigations
- Implementation roadmap
Funnel Velocity and Portfolio Throughput Optimization
Most organizations optimize individual projects on merit but treat the pipeline as a black box—projects advance, time passes, results appear. Funnel velocity analysis instruments the pipeline itself: how long does a project spend in each stage, which stage gates create bottlenecks, and do projects advance to launch predictably? This practice converts pipeline dynamics into operational data, revealing whether delays are systemic—redundant reviews, unclear advancement criteria, resource contention—or project-specific. Once visible, the friction points become addressable: eliminate duplicate gates, clarify what evidence justifies advancement, or resolve resource conflicts through explicit portfolio prioritization. Organizations practicing funnel optimization see cycle times compress and success rates rise not because individual projects improve, but because the system moves faster and gatekeepers make consistent decisions.
Leading Practice Report
Full detail: Innovation Funnel Velocity and Throughput Optimization
Benefits, core principles, success factors, metrics, risks and the implementation roadmap.
Get the full report →Innovation Time & Protected Resources Allocation
Development organizations face a structural trap: innovation requires exploration, but operational demands press for extraction—delivering on commitments, fixing issues, responding to customer requests. Without explicit time protection, exploration gets squeezed to margins. This practice carves development capacity explicitly for exploration work, with clear guardrails on what qualifies and minimal approval friction. Developers can spend a modest portion of time pursuing ideas adjacent to the roadmap, with periodic reviews of emerging concepts. The guardrails prevent misuse—exploration isn't a escape from accountability—but the protection ensures capacity survives quarterly pressure. Organizations practicing this see higher engagement among technical staff, higher retention, and a measurable increase in validated ideas progressing to development scope. The practice is particularly critical when transitioning from steady-state operations to innovation-driven strategy, since innovation capacity doesn't emerge naturally from BAU work.
Leading Practice Report
Full detail: Innovation Time & Protected Resources Allocation
Benefits, core principles, success factors, metrics, risks and the implementation roadmap.
Get the full report →Where to start
- Map your current development pipeline: list every active project, record the date it entered each stage, and calculate how many days it spent in each. Identify your three longest-stalled projects and the stage where each has spent the most calendar time. This takes two hours and will reveal whether your delays are stage-specific or organization-wide.
- Audit your stage-gate criteria: pull the last five projects that advanced to development and the last five that were rejected. Compare the stated criteria against the decision—do gatekeepers apply the same standard, or does approval seem to depend on project politics or whose idea it is? Inconsistent application of gates is invisible to leadership but kills pipeline predictability.
- Ask your development team: what percentage of their calendar time do they spend on unplanned work—urgent requests, firefighting, reactive changes—versus planned project work? If that number exceeds acceptable levels, portfolio constraints and prioritization are not working, and cycle times will remain slow no matter how good individual project execution is.
What percentage of our development team's time is being consumed by work not on the current project roadmap, and where is that demand coming from?
Start free with Ask Kepler →Emerging approaches
Advanced & Emerging Practices
Emerging practices are included with Ask Kepler Pro and Max.
Unlock these practices →How are these playbooks made? Read our methodology.